Nalaganje...
Elderly patients are at greater risk of cytopenia during antiviral therapy for hepatitis C
The results of antiviral therapy for hepatitis C virus (HCV) have improved recently with the use of pegylated interferon (PEG-IFN)/ribavirin (RBV) combination therapy. At this point, most patients with chronic HCV remain untreated. Thus, it is anticipated that therapy will be more appealing and pres...
Shranjeno v:
Main Authors: | , , , |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
Pulsus Group Inc
2006
|
Teme: | |
Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2659944/ https://ncbi.nlm.nih.gov/pubmed/17001400 |
Oznake: |
Označite
Brez oznak, prvi označite!
|